1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation
    Journal Article

    Xiao, W.; Yabe, M.; Offin, M.; Khattar, P.; Baik, J.; Daley, R. J.; Pappacena, J. J.; Roshal, M.; Zhang, Y.; Tallman, M. S.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Cytologic features of gynecologic adenocarcinomas with mesonephric features
    Meeting Abstract

    Murali, R.; Werneck Kraus Silva, V.; Fix, D.; Chiang, S.; DeLair, D.; Soslow, R.; Park, K.
    International Journal of Gynecological Cancer (2018)

    Fulltext@MSK | Save
  • Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
    Meeting Abstract

    Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Oncogenic KRAS mediates resistance to MET targeted therapy in non-small cell lung cancer (NSCLC) with MET mutations that induce exon14 skipping
    Meeting Abstract

    Suzawa, K.; Offin, M. D.; Kurzatkowski, C.; Liu, D.; Vojnic, M.; Smith, R. S.; Mattar, M.; Khodos, I.; de Stanchina, E.; Sabari, J. K.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct "alpha-cell signature" subgroup
    Meeting Abstract

    Laddha, S. V.; Chan, C. S.; Lewis, P.; Koletsky, M.; Robzyk, K.; Da Silva, E.; Torres, P. J.; Untch, B.; Bose, P.; Chan, T.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Is the decrease in the incidence of large cell carcinoma of the lung due to changes in classification towards adenocarcinoma
    Meeting Abstract

    Hashim, D.; Znaor, A.; Travis, W.; Boffetta, P.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Noninvasive profiling of molecular dynamics in patients receiving HER2 targeted therapies by cell-free DNA analysis
    Meeting Abstract

    Gedvilaite, E.; Stewart, C.; Yang, J.; Reichel, J.; Stephens, D.; Offin, M. D.; Jing, X.; Meng, F.; You, D.; Berger, M. F.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Neoadjuvant PD-1 blockade in resectable lung cancer
    Meeting Abstract

    Forde, P. M.; Chaft, J. E.; Smith, K. N.; Anagnostou, V.; Cottrell, T. R.; Hellmann, M. D.; Zahurak, M.; Yang, S. C.; Jones, D. R.; Broderick, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small cell lung carcinoma (NSCLC): A proposal for quantitative immune-related pathologic response criteria (irPRC)
    Meeting Abstract

    Cottrell, T. R.; Stein, J. E.; Chaft, J. E.; Thompson, E. D.; Rekhtman, N.; Anagnostou, V.; Smith, K. N.; Duffield, A. S.; Anders, R. A.; Isbell, J. M.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor
    Meeting Abstract

    Wang, J.; Yao, Z.; Jonsson, P.; Allen, A.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save